# Pinoxin for the Prevention of Radiation-Induced Skin Injury

> **NCT07545720** · PHASE2 · RECRUITING · sponsor: **Fudan University** · enrollment: 202 (estimated)

## Conditions studied

- Cancer Patients Undergoning Radiotherapy

## Interventions

- **DRUG:** pinoxin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07545720
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-05
- **Primary completion:** 2026-05-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 202 (ESTIMATED)
- **Last updated:** 2026-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07545720

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07545720, "Pinoxin for the Prevention of Radiation-Induced Skin Injury". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07545720. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*